Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/152301
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Leucine rich repeat kinase 2 (LRRK2) inhibitors based on indolinone scaffold: Potential pro-neurogenic agents |
Autor: | Salado, Irene G. CSIC; Zaldívar-Díez, Josefa CSIC ORCID; Sebastián, Víctor CSIC ORCID; Li, Lingling CSIC; Geiger, Larissa; González Menéndez, Silvia CSIC ORCID; Campillo, Nuria E. CSIC ORCID ; Gil, Carmen CSIC ORCID ; Morales, Aixa V. CSIC ORCID; Pérez, Daniel I. CSIC ORCID; Martínez Gil, Ana CSIC ORCID | Palabras clave: | LRRK2 inhibitors Protein kinase inhibitors Indolinone Adult neurogenesis Neural stem cells Regenerative medicine |
Fecha de publicación: | 29-sep-2017 | Editor: | Elsevier | Citación: | European Journal of Medicinal Chemistry 138: 328–342 (2017) | Resumen: | Leucine-rich repeat kinase 2 (LRRK2) is one of the most pursued targets for Parkinson’s disease (PD) therapy. Moreover, it has recently described its role in regulating Wnt signaling and thus, it may be involved in adult neurogenesis. This new hypothesis could give rise to double disease-modifying agents firstly by the benefits of inhibiting LRRK2 and secondly by promoting adult neurogenesis. Herein we report, the design, synthesis, biological evaluation, SAR and potential binding mode of indolinelike LRRK2 inhibitors and their preliminary neurogenic effect in neural precursor cells isolated from adult mice ventricular-subventricular zone. These results open new therapeutic horizons for the use of LRRK2 inhibitors as neuroregenerative agents.Moreover, the indolinone derivatives here prepared, inhibitors of the kinase activity of LRRK2, may be considered as pharmacological probes to study the potential neuroregeneration of the damaged brain. | Descripción: | 46 p.-7 fig.-1 tab. | Versión del editor: | http://dx.doi.org/10.1016/j.ejmech.2017.06.060 | URI: | http://hdl.handle.net/10261/152301 | DOI: | 10.1016/j.ejmech.2017.06.060 | ISSN: | 0223-5234 | E-ISSN: | 1768-3254 |
Aparece en las colecciones: | (CIB) Artículos (IC) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
European J. Medicinal Chemistry 2017.pdf | Postprint | 2,4 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
20
checked on 10-mar-2024
WEB OF SCIENCETM
Citations
21
checked on 18-feb-2024
Page view(s)
286
checked on 18-mar-2024
Download(s)
543
checked on 18-mar-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.